webinar register page

Topic

Risk adapted triage for cervical screening

Description

There are no clear factors for deciding who to screen for cervix cancer, other than previous abnormalities and the results of an initial test. The initial test can be either cytology or HPV testing. As we are moving towards primary HPV testing the focus here will be on the risk of disease based on a primary HPV test, how this can be refined by doing different triage tests. These include HPV genotyping, cytology, methylation, and p16 in a liquid-based sample. Algorithms for how best to employ these (depending on what is routinely available) will be discussed.

Time

Feb 12, 2021 02:00 PM in Universal Time UTC

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: EUROGIN.

Time Zone:

Your Information
Send to
Message preview	Hi there, You are invited to a Zoom webinar. When: Feb 12, 2021 02:00 PM Universal Time UTC Topic: Risk adapted triage for cervical screening Register in advance for this webinar: https://zoom.us/webinar/register/WN_1bWy280GQHKRLpfJJziNKw After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Jack Cuzick (Prof. ) Jack Cuzick is a director of Wolfson Institute of Preventive Medicine in London. He is also the head of Centre for Cancer Prevention and John Snow Professor of Epidemiology at Queen Mary, University of London. He holds a PhD in Mathematics. His current interests are in cancer epidemiology and clinical trials, with special interest in prevention and screening. He is a Chairman of the International Breast Cancer Intervention Study (IBIS) Steering Group and the ATAC trial.

webinar register page

Share via Email

Switch Time Zone

Upcoming Meetings